Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
- Conditions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 310
- Registration Number
- NCT00064194
- Locations
- 🇨🇦
Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada
🇨🇦Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
🇨🇦Princess Margaret Hospital, Toronto, Ontario, Canada
SarCNU in Treating Patients With Recurrent Malignant Glioma
- Conditions
- First Posted Date
- 2003-07-08
- Last Posted Date
- 2020-04-06
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 10
- Registration Number
- NCT00036660
- Locations
- 🇨🇦
Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada
🇨🇦Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
🇨🇦Toronto General Hospital, Toronto, Ontario, Canada
Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation
- Conditions
- First Posted Date
- 2003-07-01
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 6
- Registration Number
- NCT00031668
- Locations
- 🇨🇦
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada
🇨🇦Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
🇨🇦Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Conditions
- First Posted Date
- 2003-06-27
- Last Posted Date
- 2020-04-08
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 50
- Registration Number
- NCT00030446
- Locations
- 🇨🇦
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
🇨🇦British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada
Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
- Conditions
- First Posted Date
- 2003-05-21
- Last Posted Date
- 2020-04-09
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 17
- Registration Number
- NCT00005971
- Locations
- 🇨🇦
York County Hospital, Newmarket, Ontario, Canada
🇨🇦Women's College Campus, Sunnybrook and Women's College Health Science Center, Toronto, Ontario, Canada
🇨🇦Credit Valley Hospital, Mississauga, Ontario, Canada
Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma
- Conditions
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 18
- Registration Number
- NCT00053781
- Locations
- 🇨🇦
Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada
🇨🇦Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
🇨🇦Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer
- Conditions
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 25
- Registration Number
- NCT00054106
- Locations
- 🇨🇦
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
- Conditions
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 17
- Registration Number
- NCT00053794
- Locations
- 🇨🇦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
🇨🇦Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada
🇨🇦Mount Sinai Hospital - Toronto, Toronto, Ontario, Canada
Letrozole After Tamoxifen in Treating Women With Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 5187
- Registration Number
- NCT00003140
- Locations
- 🇨🇦
The Moncton Hospital, Moncton, New Brunswick, Canada
🇨🇦Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
🇨🇦St. Michael's Hospital, Toronto, Ontario, Canada
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 361
- Registration Number
- NCT00002633
- Locations
- 🇨🇦
QEII Health Sciences Center, Halifax, Nova Scotia, Canada
🇨🇦Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦Cancer Centre of Southeastern Ontario at Kingston, Kingston, Ontario, Canada